Abstract
We recently identified anti-β2GPI antibodies in a high proportion of sera from children with atopic dermatitis (AD) and showed that these anti- β2GPI most probably recognise domain V of β2GPI by contrast to anti-β2GPI from patients with the anti-phospholipid syndrome (APS) which epitopes apparently reside in domain I or IV. The aim of the present study was to compare the binding of IgG anti-β2GPI in AD and APS on four representative commerciallyavailable types of high binding microtiter plates. Selected plates: Costar, Nunc, Linbro and Sumilon C. Randomly selected sera from 29 children with AD and sera from 43 SLE patients (24 with secondary APS) were tested by anti-β2GPI ELISA using affinity purified β2GPI. Assays were calibrated with the HCAL, chimeric anti-β2GPI monoclonal antibodies with human γ1 constant regions. The calibration curves for HCAL were practically the same on all four types of plates. Sera from 7/24 APS patients with medium or high anti-β2GPI levels showed similar binding properties on all four plates, while 3/24 sera expressed values either slightly above or below the cut-off points. On the other hand, anti-β2GPI from AD sera showed very simmilar binding on Costar, Nunc and Linbro plates, while only 3/13 positive sera with the highest values on these 3 types of plates expressed low positive values for IgG anti-β2GPI on Sumilon C plates (Table (Table1).1). Except for one serum (low positive on Linbro plate) all sera from SLE patients without APS were negative on all the plates. Table 1 Our results point to substantial differences in the binding to β2GPI coated on different microtiter plates by anti-β2GPI in AD (with signs of APS) but not by anti-β2GPI in APS. In contrast to the other plate types, Sumilon C plates coated with β2GPI bound only minimally antibodies from AD children. If such anti-β2GPI prove non-thrombogenic, we will be able to increase the specificity of detecting anti-β2GPI relevant for APS by the use of this type of microtiter plates. Alternatively, if both anti-β2GPI specificities prove thrombogenic, we will be able to increase the sensitivity of the assay system by the use of other less discriminatory types of plates. k, slope of linear regression plot and R2 - determination coefficient: both compared to Costar. N, number of IgG anti-β2GPI positive sera in the group. *P < 0.001 (significant difference when compared with Costar, Nunc or Linbro)
Highlights
The presence of autoantibodies directed to citrullinated antigens in serum is highly specific for rheumatoid arthritis (RA)
We discuss the presence of anti-keratin antibodies (AKA) of the IgG class in patients with defined juvenile idiopathic arthritis (JIA)
Our study revealed that AKA was present overall in 18/29 patients (62%) with severe JIA and in 12/26 patients (46,2 %) with non-severe disease, this did not reach statistical significance (P = 0,18)
Summary
The presence of autoantibodies directed to citrullinated antigens in serum is highly specific for RA. Anti-CCP concentrations (expressed in Units per mg total IgG) were on average 1.34 times higher in SF compared to serum (n = 20, P < 0.05) or 1.37 when only positive samples were included (n = 11, P < 0.05) Conclusion: Citrullinated antigens are present in the synovia of both RA and control patients with similar prevalence. At higher concentrations (>1ng/μl) of RNA-oligonucleotides unspecific hybridization-signals prevailed in tissues of all diseases (even in normal controls) The combination of both methods (in situ-hybridization and immunohistochemistry) identifies the single cells inside the synovial lining layer which contains the highly expressed RAB3 “Kreisler” (maf B) gene. Conclusions: These data demonstrates for the first time that statins (and fluvastatin) are able to inhibit an endothelial proadhesive and pro-inflammatory phenotype induced by different stimuli including anti-β2GPI antibodies or pro-inflammatory cytokines These findings suggest a potential usefulness for statins in the prevention of the APS pro-atherothrombotic state
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.